|
Gene Patenting
Because biotech companies depend on private investments, patents are among the first and most important benchmarks of progress in developing a new biotechnology product. Patens offer limited protection against commercial use of a company's invention by a competitor. In biotechnology, patents are critical to raising capital to fund the research and development of products. BIO advocates strong intellectual property protection for biotechnology inventions. For this reason, the organization opposes any legislation, regulatory change by the Patent and Trademark Office (PTO) or judicial effort that would shorten the length of a patent or limit the scope and protections a patent affords.
|
